Watchlist Price Alert

Taisho Pharmaceutical Co... (TAIPY)

PNK: TAIPY · Real-Time Price · USD

14.00

null (null%)

At close: Jul 12, 2024, 8:00 PM

Taisho Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	29.5B	21.4B	22.98B	30.31B	64.48B	48.07B	41.96B	35.81B
Depreciation & Amortization	24.65B	23.07B	22.04B	16.7B	11.29B	11.38B	11.67B	12.47B
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.61B	1.5B	-4.3B	-1.21B	-9.01B	-9.96B	-691M	9.86B
Other Non-Cash Items	-11.92B	-17.52B	-6.15B	-12.33B	-47.38B	-10.8B	-11.84B	-15.55B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.26B	1.55B	3.15B	7.31B	-9.17B	-8.79B	-1.72B	10.33B
Operating Cash Flow	40.97B	28.51B	42.03B	41.99B	19.22B	39.85B	40.07B	43.06B
Capital Expenditures	-50.38B	-14.39B	-14.37B	-9.12B	-4.91B	-5.01B	-8.83B	-8.21B
Cash Acquisitions	1.51B	-4.31B	-4.08B	-160.5B	70.58B	-434M	-12.26B	-1.26B
Purchase of Investments	-3.41B	-1.27B	-2.07B	-1.86B	-18.87B	-12.47B	-20.83B	-11.15B
Sales Maturities Of Investments	7.33B	9.27B	14.04B	74.61B	29.4B	6.32B	40.75B	10B
Other Investing Acitivies	17.82B	3.63B	4.53B	-10.22B	-10.15B	-8.31B	-196M	-1.04B
Investing Cash Flow	-27.13B	-7.06B	-1.96B	-107.08B	66.04B	-19.91B	-1.36B	-11.66B
Debt Repayment	-622M	95M	-183M	-1.26B	24M	13M	58M	-125M
Common Stock Repurchased	-34M	-43M	-41M	-48M	-341M	-96M	-100M	-10.1B
Dividend Paid	-8.21B	-7.42B	-8.79B	-9.59B	n/a	-8.77B	-7.97B	-8.9B
Other Financial Acitivies	-2.02B	-2.69B	-2.33B	-798M	-6.38B	-1.01B	-388M	-400M
Financial Cash Flow	-10.88B	-10.06B	-11.35B	-11.7B	-15.47B	-9.87B	-8.4B	-19.52B
Net Cash Flow	4.56B	12.17B	28.41B	-76.61B	69.19B	10.14B	29.95B	11.23B
Free Cash Flow	-9.41B	14.12B	27.65B	32.87B	14.31B	34.84B	31.24B	34.84B